Insider trades
Avalon Ventures XI, 10% Owner of Janux Therapeutics JANX, has filed 1 purchase and 47 sales on the open market. The latest trade was on 24/10/18.
Avalon Ventures XI
10% Owner
- Company
- Janux Therapeutics JANX
- First filing
- 23/11/13
- Trades
- 97 trades
- Buys / sales
- 1 / 47
- 12-month net buying
- No record
- Last trade
- 24/10/18
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
JANX | Open-market sale | 24/10/16–24/10/18 | 24/10/18 | 1,673,128 sh17 trades | $46.30avg. | $77,472,371.23 | No record |
JANX | Open-market sale | 24/09/26–24/09/30 | 24/09/30 | 307,779 sh14 trades | $46.96avg. | $14,452,393.76 | No record |
JANX | Open-market sale | 24/09/10–24/09/12 | 24/09/12 | 451,091 sh9 trades | $46.89avg. | $21,153,619.49 | No record |
JANX | Open-market sale | 24/09/06–24/09/09 | 24/09/10 | 242,182 sh4 trades | $42.00avg. | $10,172,364.06 | No record |
JANX | Open-market sale | 24/06/03 | 24/06/05 | 1,500,000 sh3 trades | $54.75avg. | $82,125,000 | No record |
| Open-market buy | 23/11/13 | 23/11/13 | 849,854 sh | $5.87 | $4,988,642.98 | No record |